Cargando…
Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial
BACKGROUND/AIMS: Immunoglobulin A nephropathy (IgAN) is a generally progressive disease, even in patients with favorable prognostic features. In this study, we aimed to investigate the antiproteinuric effect and tolerability of low-dose valsartan (an angiotensin II receptor blocker) therapy in normo...
Autores principales: | Jo, Young-Il, Na, Ha-Young, Moon, Ju-Young, Han, Sang-Woong, Yang, Dong-Ho, Lee, Sang-Ho, Park, Hyeong-Cheon, Choi, Hoon-Young, Lim, So-Dug, Kie, Jeong-Hae, Lee, Yong-Kyu, Shin, Sug-Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773712/ https://www.ncbi.nlm.nih.gov/pubmed/26874511 http://dx.doi.org/10.3904/kjim.2014.266 |
Ejemplares similares
-
Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria
por: Lee, Yu Ho, et al.
Publicado: (2017) -
Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016) -
Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014) -
Outcomes of minimal change disease without nephrotic range proteinuria
por: Son, Hyung Eun, et al.
Publicado: (2023) -
Addition of nonalbumin proteinuria to albuminuria improves prediction of type 2 diabetic nephropathy progression
por: Kim, Jong Ho, et al.
Publicado: (2017)